NEW YORK, March 7 – Sequenom has sold a MassArray system to genetic testing giant Quest Diagnostics, Sequenom said Wednesday.

Quest will use the MassArray system to identify disease-associated genetic variations and to determine susceptibility to hereditary conditions. The system has been installed at Nichols Institute, Quest's center for research and development, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.